These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28350098)

  • 21. CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP-9/PI3K/AKT pathway.
    Chen H; Pan R; Li H; Zhang W; Ren C; Lu Q; Chen H; Zhang X; Nie Y
    Cell Biol Int; 2021 Mar; 45(3):623-632. PubMed ID: 33245175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
    Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
    Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
    Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
    Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tizanidine hydrochloride exhibits a cytotoxic effect on osteosarcoma cells through the PI3K/AKT signaling pathway.
    Xing XW; Sun YF; Zhao J; Pan ZX; Jiang WX
    J Int Med Res; 2019 Aug; 47(8):3792-3802. PubMed ID: 31179788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
    Wang S; Zhao G; Zhao S; Qiao Y; Yang H
    Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.
    Zhang HP; Yu ZL; Wu BB; Sun FR
    J Orthop Surg Res; 2020 Apr; 15(1):162. PubMed ID: 32334633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1-Associated Protein-1 Suppresses Osteosarcoma Cell Proliferation and Migration Through Regulation PI3K/Akt Pathway.
    Gao S; Sun H; Cheng C; Wang G
    DNA Cell Biol; 2017 May; 36(5):386-393. PubMed ID: 28256910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway.
    Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Wang Y; Deng Y
    J Physiol Biochem; 2020 May; 76(2):279-290. PubMed ID: 32100243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
    Li T; Xiao Y; Huang T
    Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway.
    Ren C; Pan R; Hou L; Wu H; Sun J; Zhang W; Tian X; Chen H
    Mol Med Rep; 2020 Apr; 21(4):1739-1748. PubMed ID: 32319617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulated LEPRE1 correlates with poor outcome and its knockdown attenuates cells proliferation, migration and invasion in osteosarcoma.
    Huang Z; Wang Q; Wang Y; Zhao L; Cao Z; Cui C; Yu D; Liu B
    Anticancer Drugs; 2020 Apr; 31(4):326-332. PubMed ID: 32197005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation.
    Graziano AC; Cardile V; Avola R; Vicario N; Parenti C; Salvatorelli L; Magro G; Parenti R
    Oncotarget; 2017 Feb; 8(8):13917-13931. PubMed ID: 28107196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling.
    Meng ZJ; Wu N; Liu Y; Shu KJ; Zou X; Zhang RX; Pi CJ; He BC; Ke ZY; Chen L; Deng ZL; Yin LJ
    Oncol Rep; 2015 Sep; 34(3):1388-96. PubMed ID: 26135006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
    Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
    J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway.
    Liu M; Zhang J; Dong H; Wang W
    J Cell Physiol; 2019 Nov; 234(11):20879-20887. PubMed ID: 31001861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
    Tan S; Chao R
    Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
    Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
    Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway.
    Qiu C; Su W; Shen N; Qi X; Wu X; Wang K; Li L; Guo Z; Tao H; Wang G; Chen B; Xiang H
    BMC Cancer; 2020 Dec; 20(1):1187. PubMed ID: 33272245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.